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Abstract
Background: Feline cytauxzoonosis is an emerging infection caused by tick-transmitted apicomplexan parasites of
the genus Cytauxzoon. The association of clinical disease with Cytauxzoon infection appears to be limited to C. felis
infections in the Americas. Sporadic infections of wild and domestic felids with Cytauxzoon sp. were recently
described in European countries but clinical reports of the infection are rare and incomplete. This case report brings
new interesting information on cytauxzoonosis expression in Europe.
Case presentation: A 9-years-old castrated European shorthair cat living in rural area of north-eastern France
(Saint Sauveur, Bourgogne-Franche-Comté region), without any travel history was presented for consultation due to
hyperthermia, anorexia, depression and prolonged fever that didn’t respond to antibiotic therapy. The cat had
outdoor access with a history of vagrancy and was adequately vaccinated (core vaccines and FeLV vaccine). During
biological investigations, intraerythrocytic inclusions were observed on blood smear and were further investigated
by PCR analysis and sequencing. Molecular analyses confirmed Cytauxzoon sp. infection. The cat was treated with a
subcutaneous injection of imidocarb dipropionate (3.5 mg/kg). One week after treatment, the cat improved
clinically, although parasitic inclusions within erythrocytes persisted, and only a mild lymphocytosis was found. Two
weeks after treatment, the cat appeared in excellent health, appetite was normal and parasitemia was negative.
However, one month after treatment the cat relapsed with hyperthermia, anorexia, and depression. Blood smears
and PCR were once again positive. Subsequently, the cat received an additional dose of imidocarb dipropionate
(3.5 mg/kg SC) and recovered rapidly without other clinical signs. Two weeks after the second imidocarb injection,
the cat was hit by a car and died.
Conclusion: This case provides the first clinical description of infection by Cytauxzoon sp. in a domestic cat in
France. These findings support the fact that cytauxzoonosis should be considered in the differential diagnosis of
acute febrile illness which does not respond to antibiotic in cats with outdoor access especially in areas where
populations of wild felids are present.
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Background
Feline cytauxzoonosis is an emerging infectious disease
with an expanding geographic distribution caused by tick-
borne apicomplexan parasites of the genus Cytauxzoon.
Cytauxzoonosis was first identified in 1973 as the cause of
mortality in domestic cats in Missouri, USA [1].
Cytauxzoon or Cytauxzoon-like parasites have been
reported in various domestic and wild felids throughout
the World [2, 3]. Cytauxzoon felis is considered as the
main agent of the disease in domestic cats, mostly de-
scribed in USA. Dermacentor variabilis and Amblyomma
americanum have been shown to be the tick vectors of
this pathogen [4, 5]. C. felis is responsible for a severe,
often fatal disease associating clinical signs such as
anemia, depression, anorexia, vomiting, icterus, spleno-
megaly, hepatomegaly and high fever [6].
However, with rare exceptions, the recognition of clin-
ical disease caused by parasites of the genus Cytauxzoon
appears limited to C. felis infections in the Americas.* Correspondence: Lenaig.HALOS@Merial.com2Merial, Lyon, France
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Sporadic infections of wild and domestic felids with a
new and genetically distinct species described as “Cytaux-
zoon sp.” were reported in European countries such as
Spain [7–11], France [11], Italy [12–14], Portugal [15], and
Romania [16], but reports presenting clinical expression of
the infection are rare and incomplete. Cytauxzoon sp. in
Europe seems less virulent than C. felis and it was sug-
gested that disease associated with it could develop prefer-
entially in case of concurrent disease or immunodeficiency
[12]. Hemolytic anemia, lethargy, fever, anorexia, weight
loss, diarrhea and vomiting were occasionally described in
association with Cytauxzoon sp. infection [12, 13, 15]. A
high rate of asymptomatic carriage of Cytauxzoon sp.
in domestic cats was reported in a study conducted
in Northern Italy [12]. In France, a previous study
reported the case of a cat found co-infected with
Hepatozoon canis and Cytauxzoon sp. The agents
were molecularly characterized but no information on
the epidemiology, clinical history, clinical course of
infection and therapy was available [11]. Consequently,
knowledge on the epidemiology, risk factors and clinical
course of infection of felids with Cytauxzoon sp. in
European countries and in particular in France is still
unclear and needs further investigation. This study
provides the first clinical description of infection by
Cytauxzoon sp. in a domestic cat in France.
Case presentation
Clinical history
A 9-years-old neutered male European shorthair cat
weighting 6 kg and living in a rural area (Saint Sauveur,
France: 47°48′N, 6°23′E), without any travel history
was presented to consultation for lethargy, anorexia,
hemorrhagic diarrhea, and abdominal pain. The cat
had permanent outdoor access and was vaccinated
against feline panleukopenia, viral rhinotracheitis, cali-
civirus and feline leukemia virus.
Two weeks before consultation, the cat came back from
4 days vagrancy with hyperthermia (41 °C), lethargy,
anorexia, dehydration and weight loss. The cat didn’t
recover within the following 15 days despite antibiotic
therapy of amoxicillin and clavulanic acid at 10 mg and
2.5 mg/kg respectively (Clavaseptin, Vetoquinol) adminis-
tered orally every 12 h for 10 days.
Clinical findings and investigation (Table 1)
Clinical examination showed hyperthermia (40.5 °C),
abdominal pain and subcutaneous hematomas on the
abdomen. Sepsis resulting from a possible fight during
vagrancy was suspected and subcutaneous injections of
marbofloxacin (Marbocyl, Vetoquinol, 2 mg/kg) and
carprofen (Rimadyl, Zoetis, 4 mg/kg) were performed
followed by marbofloxacin (Marbocyl, Vetoquinol) 2 mg/
Table 1 Timeline table of the information of the case report
Day (D) Findings Treatment
Clinical observation Clinical investigation
D-14 Clinical history: hyperthermia (41 °C), lethargy, anorexia, dehydration and weight loss after
4 days vagrancy
amoxicillin (10 mg/kg) + clavulanic acid
(2.5 mg/kg) orally every 12 h for 10 days.
D0 hyperthermia (40.5 °C), abdominal pain and subcutaneous hematomas on the abdomen marbofloxacin (2 mg/kg) and carprofen
(4 mg/kg) marbofloxacin (2 mg/kg PO
once daily for 10 days
meloxicam 0.05 mg/kg PO once daily
for 5 days
D7 to D29 neutrophilic leukocytosis at the complete blood
counts (CBC),
biochemical, serological and molecular analyses
for different infectious disease: all negative
Abdominal, pulmonary and oral X-ray: normal except a
marked splenomegaly
oropharyngeal swab for the detection of calicivirus and
feline herpes virus were conducted




Stained blood smear of peripheral blood: small inclusions
within erythrocytes
PCR identification of Cytauxzoon sp.
imidocarb dipropionate 3.5 mg/kg/
subcutaneous injection).
Day 37 Clinical improvement Inclusions present in the blood smear
Day 46 Excellent general conditions No more inclusions in the blood smear
Day 63 Relapse: hyperthermia, anorexia
depression and stomatitis
Inclusions present in the blood smear
PCR positive for Cytauxzoon sp.
imidocarb dipropionate 3.5 mg/kg/
subcutaneous injection).
Day 69 Clinical recovery hypergammaglobulinemia with hyperproteinemia
(91 g/L; reference range: 57 – 94 g/L) with an hematocrit
at the lower limit of the reference range (28 L/L; reference
range: 28 – 45).
Absence of inclusion in the blood smear
Day 76 Death by car accident
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kg PO once daily for 10 days and meloxicam (Metacam,
Boehringer Ingelheim) at 0.05 mg/kg PO once daily for
5 days for pain and fever relief.
The cat was rechecked 29 days later. The owner reported
no clinical improvement despite proper administration of
the treatment and subsequent vomiting, stomatitis, cranial
right abdomen pain, hyperthermia, anorexia and severe
depression were noticed. The cat was hospitalized and
received symptomatic treatment against vomiting (maropi-
tant, Cerenia, Zoetis, SC injection, 1 mg/kg) as well as a
corticosteroid (dexamethasone tebutate, Dexamedium,
MSD, SC injection, 0.1 mg/kg) and antibiotics (amoxicillin,
Duphamox LA, Zoetis, SC injection, 15 mg/kg every other
day for 1 week, followed by cefovecine, Convenia, Zoetis,
SC injection, 8 mg/kg).
Blood samplings were performed on days 7, 18, 21 and
29 for complete blood counts (CBC), and/or biochem-
ical, serological and molecular analyses of common in-
fectious diseases. Abdominal, pulmonary and oral X-ray
with oropharyngeal swab for the detection of calicivirus
and feline herpes virus were conducted.
Differential diagnosis
The rapid immune-migration test for feline leukemia virus
and feline immunodeficiency virus diagnosis (Witness®,
Synbiotics corp.), Coombs test and PCR for the detection
of feline hemotropic mycoplasms (Mycoplasma haemofelis
and Candidatus Mycoplasma haemominutum) were all
negatives. PCR detection of calicivirus and feline herpes
virus on the oropharyngeal swab were also negative and
the X-rays were interpreted as normal with the exception
of a marked splenomegaly.
The CBC performed on day 7 (Table 2) showed red blood
cells count within normal limits, an increased white blood
cells count (WBC: 25.3 × 109/L; reference range: 5 – 11)
with neutrophilic leucocytosis (neutrophils: 17.7 × 109/L,
confirmed on blood smear with relatively frequent Döhle
inclusion bodies; reference range: 3 – 11), and eosinophilia
(eosinophils: 1.8 × 109/L; reference range: 0 – 0.6).
Serum biochemistry indicated an hypertriglyceridemia
(7.14 mmol/L; reference range: 0.13 – 1.61) whereas all
other biochemical parameters tested including urea,
creatinine, glucose, ALT, ALKP, and lipase were within
normal limits.
The stained blood smear of peripheral blood exam-
ined on day 29 revealed small inclusions within eryth-
rocytes (Fig. 1) with uniform distribution on the smear
(one red blood cell inclusion for two fields at high
magnification: ×1000). The inclusions had an annular
shape and were 0.5-0.8 μm in diameter suggesting the
possibility of infection with and unidentified small
piroplasmid parasite. A marked agglutination of eryth-
rocytes was also noted on slide. No schizont-infected
myeloid cells were detected. The blood smears done
previously (on day 7, 18 and 21) were not available to
be re-assessed.
Final diagnosis
DNA was extracted from whole blood collected in EDTA
on day 29 and was simultaneously analyzed by PCRs on
the 18S rRNA gene of the Piroplasmida in three different
laboratories (Scanelis laboratory, Toulouse, France; Labora-
tory of Parasitology and Parasitic diseases, Vetagro Sup,
Marcy-l’Etoile, France; and Koret School of Veterinary
Medicine laboratory at the Hebrew University) following
the conditions summarized in Table 3 [17, 18]. PCR was
positive in all laboratories and the amplified DNA was
sequenced. The three overlapping sequences of 18S rDNA
Table 2 Summary of blood cell counts at the time of diagnosis and at the last recheck before the cat’s death with maximum and
minimum values observed during the 78 days of follow-up
Parameter (unit) Reference interval Initial analysis (day 7) Last analysis (day 69) Minimum and maximum value during follow-up
RBCa (1012/L) 5 – 10 8.00 8.73 6.75 – 8.73
Hemoglobin (g/L) 90 – 150 122 115 102 – 115
Hematocrit (L/L) 28 – 45 36.0 28 28 – 37.1
MCVb (fL) 40 – 55 45 32 32 – 47
MCHCc (g/L) 310 – 350 339 410 280 – 345
WBCd (109/L) 5 – 11 25.3 15.0 11 – 12.8
Neutrophils (109/L) 3 – 11 17.7 7.6 5.4 – 9.25
Eosinophils (109/L) 0 – 0.6 1.8 0.95 0.15 – 0.5
Monocytes (109/L) 0 – 0.5 0.500 0.55 0.15–1.85
Lymphocytes (109/L) 1 – 6 5.3 5.9 3–6.5
Platelets (109/L) 150 – 550 165 305 305 – 441
a RBC red blood cells count
b MCV mean corpuscular volume
c MCHC mean corpuscular hemoglobin concentration
d WBC white blood cells count
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fragments obtained from each laboratory were 100%
homologous to each other in the common fragments.
A consensus sequence of 944 bp was deposited in
Genbank under accession number KX881967. Com-
parison of this consensus sequence to sequences
deposited in GenBank® using the basin local align-
ment search tool (BLAST) (https://blast.ncbi.nlm.nih.-
gov/Blast.cgi) as well as phylogenetic analyses (Fig. 2)
affiliated the organism found in the cat’s blood to
Cytauxzoon sp. with 99% identity with sequences of
Cytauxzoon sp. previously detected from domestic
cats in France (EU622908) and Spain (AY309956) and
from wild lynxes in Spain (EF094468 to EF094473). It
also had a 99% identity with Cytauxzoon manul from
Mongolian wild cats (AY485690 and AY485691).
Treatment, outcome and follow-up
On day 29, the cat was treated with a subcutaneous injec-
tion of imidocarb dipropionate (Carbesia, MSD, 3.5 mg/kg).
One week after treatment (day 37), the cat improved
clinically, however, intraerythrocytic inclusions were still
present, and a mild lymphocytosis was noticed on the
blood smear.
Two weeks after treatment (day 46), the cat ap-
peared in excellent health, appetite was normal and
parasitemia was negative by blood smear microscopic
examination.
However, one month after treatment (day 63) the cat
relapsed and was presented with a new episode of hyper-
thermia, anorexia depression and stomatitis. CBC was
within the normal values, but intraerythrocytic inclu-
sions were again present on the blood smears and PCR
was positive. The cat received an additional injection of
imidocarb dipropionate (3.5 mg/kg SC) and recovered
rapidly without other clinical signs. An extended CBC
and a serum protein analysis performed 7 days later (on
day 69) indicated an hypergammaglobulinemia with
hyperproteinemia (91 g/L; reference range: 57 – 94 g/L)
with an hematocrit at the lower limit of the reference
range (28 L/L; reference range: 28 – 45). Oropharyngeal
examination was normal.
Unfortunately, two weeks after the second imidocarb
injection (day 76), the cat was hit by a car and died. This
didn’t allow further clinical investigations.
Post-mortem examination
No specific macroscopic lesions related to the cat’s
disease were found on gross pathology. Post-mortem
Fig. 1 Stained blood smear showing Cytauxzoon sp. parasite in
cat erythrocyte
Table 3 List of the primers used for the amplification of 3 overlapping fragments of 18S rDNA of piroplasms






930 bp 94 °C 3 min,
58 °C 1 min











836 bp Same conditions for the secondary round





1188 94 °C 3 min
45 cycles:
94 °C 20 s
56 °C 30 s
72 °C 45 s




AAT ACC CAA TCC TGACAC AGG G
TTA AAT ACG AAT GCC CCC AAC
408 bp 94 °C 1 min
39 cycles
94 °C 45 s,
62 °C 45 s,
72 °C 45 s.
72 °C 7 min
[18]
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samples from the liver, spleen, kidney, iliac lymph node,
lung and bone marrow as well as smears from the
lung, spleen and marrow were collected and sent to
the laboratory of Histology, VetAgro Sup, Marcy
l’Etoile, France, for cytology and histology. Cytaux-
zoon schizonts were not encountered in the macro-
phages of any tissue. Layers from lungs showed
suspicious inclusions in macrophages that could not
be more precisely characterized. The histopathological
findings observed included hyperplasia of the pan-
creas and of the spleen as well as an extended renal
cortical inflammatory lesion. Changes in the lungs
tissues related to the car crash were also noticed.
Discussion
The present case is the first report of a relapsing fever
responsive to treatment with imidocarb dipropionate
associated with Cytauxzoon sp. infection in a cat in
France. It describes the course of the infection and
brings new information about clinical expression of
suspected cytauxzoonosis in the domestic cat in Europe.
The clinical signs reported here correspond to the
signs previously described during infection with Cytaux-
zoon sp. (and usually described in case of piroplasms
infection in other species). The facts that (i) no other
cause (infectious in particular) could be evidenced, that
(ii) intra-erythrocytic inclusions were systematically
Fig. 2 Phylogenetic analysis based on 944-bp of 18S rDNA sequences of Babesia and Cytauxzoon species infecting wild and domestic Felids.
Consensus sequence from the infected cat described in the present case report is indicated by an arrow. Identity and Genbank® accession
numbers are indicated for each sample. The phylogenetic tree was constructed using the Hasegawa, Kishino and Yano maximum likelihood
method, with bootstrap analysis with 1000 replicates. The tree was rooted using Babesia canis as an outgroup. Subsequent analyses using the
Kimura’s two-parameter (K2P) distance and the parsimony methods in the same conditions confirmed the topology of the tree
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detected in acute phases of the disease and that (iii)
clinical improvement was noticed after treatment with
imidocarb dipropionate, highly comfort the role of
Cytauxzoon sp. in the clinical signs observed. However it
is not possible to ascertain that no other concurrent
disease was present. Experimental infection should be
conduct in the future to assess the clinical expression of
European Cytauxzoon sp. infection.
Based upon results from the sequencing and the
phylogenetic analyses performed on the 18S ribosomal
RNA genes, Cytauxzoon sp. detected in this clinical case
presented a high homology (99%) with Cytauxzoon sp.
and Cytauxzoon manul previously detected in wild and
domestic felids from Europe and Mongolia [7, 9, 11, 19].
In contrast, the sequence revealed an identity of only
95% with C. felis sequences deposited in GenBank®. The
parasites described from Europe as Cytauxzoon sp. are
closely related and may belong to the same species. They
are distinct from Cytauxzoon felis, the agent of feline
cytauxzoonosis in the New World.
Epidemiological and clinical data on Cytauxzoon sp.
infection in domestic and wild felids in Europe have
rarely been reported and originate from Spain, Italy,
France, Portugal and Romania [7, 9–13, 15, 16].
In the domestic cat, single occasional molecular detec-
tions of Cytauxzoon sp. have been described in France
[11] and Spain [11] with no associated clinical finding.
More recently, widespread Cytauxzoon sp. infection (up
to 23% prevalence by PCR) have been documented in
a population of domestic cats living in Trieste in
North-Eastern Italy [12]. Infection was sub-clinical in
the majority of infected cats, however, clinical signs
were described in 3 cats. Additional clinical cases have
been reported in 2 young cats from Central Italy [13]
and in a domestic cat from Portugal [15]. The clinical
signs and history reported for Italian cats [12, 13], in-
cluded gastro-intestinal disorders (vomiting, diarrhea),
weight loss, hyperthermia (>40 °C), stomatitis, ulcera-
tive dermatitis, and lethargy. Persistent parasitemia
was also described [12]. A similar clinical pattern was
observed in the present case characterized by nonspe-
cific signs of acute febrile illness including lethargy
and hyperthermia without a marked impact on the
CBC and serum biochemical parameters. Stomatitis
and persistent parasitemia despite clinical improve-
ment were also described. This pattern appears to
differ in severity compared to what is described in the
US. Cytauxzoonosis due to C. felis is characterized by
an acute febrile illness with profound fever (although
hypothermia may be identified in moribund cats),
depression and vocalization (so-called death yowl). La-
boratory abnormalities at the time of presentation are
more marked and include frequent thrombocytopenia
and neutropenia as well as non-regenerative anemia,
leukopenia, hyperbilirubinemia and bilirubinuria, mild ele-
vations in liver enzymes, hyperglycemia and hypoalbumin-
emia [2, 3]. Interestingly, the Portuguese case was evocative
of the American disease. The cat displayed a panel of signs
compatible with a severe hemolytic disease including
anemia, leukocytosis, thrombocytopenia and azotemia [15].
However, genetic analyses clustered the Portuguese
sequence with European Cytauxzoon sp. [15].
Supportive and critical treatment is a mainstay of
therapy for American cytauxzoonosis [2, 3, 20]. Clinical
recovery is not rapid with most patients getting worse
during the first 24-48 h followed by a gradual improve-
ment over the next several days. A randomized clinical
trial demonstrated survival rates of 60% with a combin-
ation of atovaquone and azithromycin compared to 27%
with imidocarb dipropionate [21]. In the Italian studies,
treatments were based on different combinations of anti-
protozoal drugs with antibiotics and steroids. One cat
received a combination of imidocarb dipropionate and
enrofloxacin 15 days apart followed by doxycycline, azi-
thromycin and atovaquone without clinical improvement
and was eventually euthanized. A second was treated
with azithromycin, enrofloxacin and prednisone and sur-
vived, while a third cat received a single administration
of azithromycin and imidocarb dipropionate and was
euthanized in the absence of improvement [12]. The two
other cats [13] were initially treated with doxycycline,
followed by imidocarb dipropionate injections (5 mg/kg,
IM injection, for two times 2 weeks apart). The 2 cats
improved during a follow-up period of 175 days and
130 days respectively, and the treatment seemed to elim-
inate Cytauxzoon sp. infection. The Portuguese cat re-
ceived daily administration of azithromycin (10 mg/kg)
alone, and the animal died despite supportive care [15].
In our case, it is difficult to assert the clinical improve-
ment as the cat accidentally died after a relapse and a
second treatment with imidocarb dipropionate at a
monthly interval.
Interestingly, detection of schizont-infected white
blood cells on the initial blood smear wasn’t noticed in
any of the European cases, including the present one. In
the US, the identification of schizont-infected myeloid
cells confirms acute cytauxzoonosis due to C. felis. The
absence of detection of schizonts may be related to a
difference in the schizogony of the species present in
Europe. This would need further investigation. No
schizont-infected cells were either identified at necropsy.
Infection with Cytauxzoon sp. is usually associated
with an outdoor life style. This is probably consistent
with the suspected tick-borne transmission mode of this
infection. The vector species of cytauxzoonosis in
Europe is not identified yet. Interestingly, as for the
Italian study of Carli et al. in 2012 [12], the cat in our
report originated from an area close to the region where
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the presence of Eurasian lynx (Lynx lynx) was docu-
mented and where wild cats (Felis silvestris) are also
present. Cytauxzoon sp. was also detected in Iberian
lynxes (Lynx pardinus) from southern Spain [9, 10] sug-
gesting a circulation of this parasite in wild and domestic
felid populations of given areas. Additional studies are
needed to understand the biology of the European
species of Cytauxzoon and their distribution in European
countries.
Conclusion
This case provides the first clinical description of disease
associated with Cytauxzoon sp. in a domestic cat in
France. While further investigations are needed to under-
stand the relationship of the European strains of Cytaux-
zoon with the observed symptoms, these findings support
the fact that cytauxzoonosis should be considered in the
differential diagnosis of acute fever not responsive to anti-
biotic treatment in cats with outdoor access, especially in
areas where populations of wild felids are present.
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